Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
71,941,794
-
Total 13F shares
-
68,071,838
-
Share change
-
-1,584,714
-
Total reported value
-
$16,777,906,026
-
Put/Call ratio
-
49%
-
Price per share
-
$246.08
-
Number of holders
-
605
-
Value change
-
-$360,225,113
-
Number of buys
-
299
-
Number of sells
-
291
Institutional Holders of WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) as of Q3 2022
As of 30 Sep 2022,
WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) was held by
605 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
68,071,838 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, FRANKLIN RESOURCES INC, APG Asset Management N.V., FMR LLC, Bank of New York Mellon Corp, T. Rowe Price Investment Management, Inc., and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
615
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.